{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:38:35Z","timestamp":1795167515976,"version":"4.10.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1186\/s13054-022-03911-7","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T11:16:55Z","timestamp":1648207015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Vasopressor Choice and Timing in Vasodilatory Shock"],"prefix":"10.1186","volume":"26","author":[{"given":"Patrick M.","family":"Wieruszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"3911_CR1","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMra1208943","volume":"369","author":"JL Vincent","year":"2013","unstructured":"Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726\u201334.","journal-title":"N Engl J Med"},{"key":"3911_CR2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/CCM.0000000000003763","volume":"47","author":"AK Khanna","year":"2019","unstructured":"Khanna AK, Maheshwari K, Mao G, et al. Association between mean arterial pressure and acute kidney injury and a composite of myocardial injury and mortality in postoperative critically ill patients. Crit Care Med. 2019;47:910\u20137.","journal-title":"Crit Care Med"},{"key":"3911_CR3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00134-018-5218-5","volume":"44","author":"K Maheshwari","year":"2018","unstructured":"Maheshwari K, Nathanson BH, Munson SH, et al. The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients. Intensive Care Med. 2018;44:857\u201367.","journal-title":"Intensive Care Med"},{"key":"3911_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"3911_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13613-019-0498-7","volume":"9","author":"TWL Scheeren","year":"2019","unstructured":"Scheeren TWL, Bakker J, De Backer D, et al. Current use of vasopressors in septic shock. Ann Intensive Care. 2019;9:20.","journal-title":"Ann Intensive Care"},{"key":"3911_CR6","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc13868","volume":"18","author":"V Beck","year":"2014","unstructured":"Beck V, Chateau D, Bryson GL, et al. Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care. 2014;18:R97.","journal-title":"Crit Care"},{"key":"3911_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","volume":"154","author":"JC Jentzer","year":"2018","unstructured":"Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB. Management of refractory vasodilatory shock. Chest. 2018;154:416\u201326.","journal-title":"Chest"},{"key":"3911_CR8","first-page":"99","volume-title":"Annual update in intensive care and emergency medicine","author":"S Vallabhajosyula","year":"2018","unstructured":"Vallabhajosyula S, Jentzer JC, Khanna AK. Vasodilatory shock in the ICU: perils, pitfalls and therapeutic options. In: Vicnent JL, editor. Annual update in intensive care and emergency medicine. Basel: Springer; 2018. p. 99\u2013111."},{"key":"3911_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/cc12727","volume":"17","author":"MW D\u00fcnser","year":"2013","unstructured":"D\u00fcnser MW, Takala J, Brunauer A, Bakker J. Re-thinking resuscitation: leaving blood pressure cosmetics behind and moving forward to permissive hypotension and a tissue perfusion-based approach. Crit Care. 2013;17:326.","journal-title":"Crit Care"},{"key":"3911_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF01819137","volume":"3","author":"CS Garrard","year":"1993","unstructured":"Garrard CS, Kontoyannis DA, Piepoli M. Spectral analysis of heart rate variability in the sepsis syndrome. Clin Auton Res. 1993;3:5\u201313.","journal-title":"Clin Auton Res"},{"key":"3911_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","volume":"95","author":"DW Landry","year":"1997","unstructured":"Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122\u20135.","journal-title":"Circulation"},{"key":"3911_CR12","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/cc12809","volume":"17","author":"K Mederle","year":"2013","unstructured":"Mederle K, Schweda F, Kattler V, et al. The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Crit Care. 2013;17:R130.","journal-title":"Crit Care"},{"key":"3911_CR13","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1097\/00003246-200109000-00016","volume":"29","author":"M Bucher","year":"2001","unstructured":"Bucher M, Hobbhahn J, Kurtz A. Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med. 2001;29:1750\u20135.","journal-title":"Crit Care Med"},{"key":"3911_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/emp2.12060","volume":"1","author":"LP Black","year":"2020","unstructured":"Black LP, Puskarich MA, Smotherman C, Miller T, Fernandez R, Guirgis FW. Time to vasopressor initiation and organ failure progression in early septic shock. J Am Coll Emerg Physicians Open. 2020;1:222\u201330.","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"3911_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jcrc.2019.11.004","volume":"55","author":"D Colon Hidalgo","year":"2020","unstructured":"Colon Hidalgo D, Patel J, Masic D, Park D, Rech MA. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care. 2020;55:145\u20138.","journal-title":"J Crit Care"},{"key":"3911_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s13054-014-0532-y","volume":"18","author":"X Bai","year":"2014","unstructured":"Bai X, Yu W, Ji W, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care. 2014;18:532.","journal-title":"Crit Care"},{"key":"3911_CR17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","volume":"44","author":"MM Levy","year":"2018","unstructured":"Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med. 2018;44:925\u20138.","journal-title":"Intensive Care Med"},{"key":"3911_CR18","doi-asserted-by":"crossref","unstructured":"Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med. 2019;199:1097\u2013105.","DOI":"10.1164\/rccm.201806-1034OC"},{"key":"3911_CR19","doi-asserted-by":"publisher","unstructured":"Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR. Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock. Crit Care Med. 2021; Sep 24. https:\/\/doi.org\/10.1097\/CCM.0000000000005317. Epub ahead of print.","DOI":"10.1097\/CCM.0000000000005317"},{"key":"3911_CR20","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1056\/NEJMra1309483","volume":"371","author":"JA Kraut","year":"2014","unstructured":"Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371:2309\u201319.","journal-title":"N Engl J Med"},{"key":"3911_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jcrc.2017.06.024","volume":"42","author":"A Javed","year":"2017","unstructured":"Javed A, Guirgis FW, Sterling SA, et al. Clinical predictors of early death from sepsis. J Crit Care. 2017;42:30\u20134.","journal-title":"J Crit Care"},{"key":"3911_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jcrc.2014.10.027","volume":"30","author":"DO Thomas-Rueddel","year":"2015","unstructured":"Thomas-Rueddel DO, Poidinger B, Weiss M, et al. Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock. J Crit Care. 2015;30:e1-6.","journal-title":"J Crit Care"},{"issue":"435","key":"3911_CR23","first-page":"e9","volume":"26","author":"G Hernandez","year":"2011","unstructured":"Hernandez G, Castro R, Romero C, et al. Persistent sepsis-induced hypotension without hyper-lactatemia: is it really septic shock? J Crit Care. 2011;26(435):e9-14.","journal-title":"J Crit Care"},{"key":"3911_CR24","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/cc8888","volume":"14","author":"AD Nichol","year":"2010","unstructured":"Nichol AD, Egi M, Pettila V, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care. 2010;14:R25.","journal-title":"Crit Care"},{"key":"3911_CR25","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1097\/CCM.0b013e3181a0f919","volume":"37","author":"TC Jansen","year":"2009","unstructured":"Jansen TC, van Bommel J, Woodward R, Mulder PGH, Bakker J. Association between blood lactate levels, sequential organ failure assessment subscores, and 28-day mortality during early and late intensive care unit stay: a retrospective observational study. Crit Care Med. 2009;37:2369\u201374.","journal-title":"Crit Care Med"},{"key":"3911_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","volume":"8","author":"GL Sacha","year":"2018","unstructured":"Sacha GL, Lam SW, Duggal A, et al. Predictors of response to fixed-dose vasopressin in adult patients with septic shock. Ann Intensive Care. 2018;8:35.","journal-title":"Ann Intensive Care"},{"key":"3911_CR27","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","volume":"159","author":"PM Wieruszewski","year":"2021","unstructured":"Wieruszewski PM, Wittwer ED, Kashani KB, et al. Angiotensin II infusion for shock. Chest. 2021;159:596\u2013605.","journal-title":"Chest"},{"key":"3911_CR28","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jvs.2018.01.050","volume":"68","author":"GJ Landry","year":"2018","unstructured":"Landry GJ, Mostul CJ, Ahn DS, et al. Causes and outcomes of finger ischemia in hospitalized patients in the intensive care unit. J Vasc Surg. 2018;68:1499\u2013504.","journal-title":"J Vasc Surg"},{"key":"3911_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","volume":"44","author":"C Martin","year":"2015","unstructured":"Martin C, Medam S, Antonini F, et al. Norepinephrine: not too much, too long. Shock. 2015;44:305\u20139.","journal-title":"Shock"},{"key":"3911_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcrc.2020.10.023","volume":"61","author":"ED Wieruszewski","year":"2021","unstructured":"Wieruszewski ED, Jones GM, Samarin MJ, Kimmons LA. Predictors of dysrhythmias with norepinephrine use in septic shock. J Crit Care. 2021;61:133\u20137.","journal-title":"J Crit Care"},{"key":"3911_CR31","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1056\/NEJMoa1701380","volume":"376","author":"KM Rowan","year":"2017","unstructured":"Rowan KM, Angus DC, Bailey M, et al. Early, goal-directed therapy for septic shock\u2014a patient-level meta-analysis. N Engl J Med. 2017;376:2223\u201334.","journal-title":"N Engl J Med"},{"key":"3911_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1378\/chest.12-1106","volume":"143","author":"SM Brown","year":"2013","unstructured":"Brown SM, Lanspa MJ, Jones JP, et al. Survival after shock requiring high-dose vasopressor therapy. Chest. 2013;143:664\u201371.","journal-title":"Chest"},{"key":"3911_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","volume":"7","author":"T Auchet","year":"2017","unstructured":"Auchet T, Regnier M-A, Girerd N, Levy B. Outcome of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care. 2017;7:43.","journal-title":"Ann Intensive Care"},{"key":"3911_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4037\/ajcc2013748","volume":"22","author":"D D\u00f6pp-Zemel","year":"2013","unstructured":"D\u00f6pp-Zemel D, Groeneveld AJ. High-dose norepinephrine treatment: determinants of mortality and futility in critically ill patients. Am J Crit Care. 2013;22:22\u201332.","journal-title":"Am J Crit Care"},{"key":"3911_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/0310057X0903700212","volume":"37","author":"CR Jenkins","year":"2009","unstructured":"Jenkins CR, Gomersall CD, Leung P, Joynt GM. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study. Anaesth Intensive Care. 2009;37:286\u20139.","journal-title":"Anaesth Intensive Care"},{"key":"3911_CR36","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jpainsymman.2016.12.333","volume":"53","author":"DA Brand","year":"2017","unstructured":"Brand DA, Patrick PA, Berger JT, et al. Intensity of vasopressor therapy for septic shock and the risk of in-hospital death. J Pain Symptom Manag. 2017;53:938\u201343.","journal-title":"J Pain Symptom Manag"},{"key":"3911_CR37","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877\u201387.","journal-title":"N Engl J Med"},{"key":"3911_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1164\/rccm.200903-0332OC","volume":"181","author":"T Nakada","year":"2010","unstructured":"Nakada T, Russell JA, Boyd JH, et al. \u03b22-adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am J Respir Crit Care Med. 2010;181:143\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"3911_CR39","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1097\/CCM.0b013e318218665a","volume":"39","author":"T Nakada","year":"2011","unstructured":"Nakada T, Russell JA, Boyd JH, et al. Association of angiotensin II type 1 receptor- associated protein gene polymorphism with increased mortality in septic shock. Crit Care Med. 2011;39:1641\u20138.","journal-title":"Crit Care Med"},{"key":"3911_CR40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1378\/chest.10-2517","volume":"139","author":"T Nakada","year":"2011","unstructured":"Nakada T, Russell JA, Wellman H, et al. Leucyl\/cystinyl aminopeptidase gene variants in septic shock. Chest. 2011;139:1042\u20139.","journal-title":"Chest"},{"key":"3911_CR41","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1097\/CCM.0000000000001853","volume":"44","author":"J Fisher","year":"2016","unstructured":"Fisher J, Douglas JJ, Linder A, Boyd JH, Walley KR, Russell JA. Elevated plasma angiopoietin-2 levels are associated with fluid overload, organ dysfunction, and mortality in human septic shock. Crit Care Med. 2016;44:2018\u201327.","journal-title":"Crit Care Med"},{"key":"3911_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","volume":"50","author":"M Jeyaraju","year":"2022","unstructured":"Jeyaraju M, McCurdy MT, Levine AR, et al. Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients. Crit Care Med. 2022;50:50\u201360.","journal-title":"Crit Care Med"},{"key":"3911_CR43","doi-asserted-by":"crossref","unstructured":"Bellomo R, Forni LG, Busse LW, et al. Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial. Am J Respir Crit Care Med. 2020;202:1253\u201361.","DOI":"10.1164\/rccm.201911-2172OC"},{"key":"3911_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/phar.2346","volume":"40","author":"JR Yerke","year":"2020","unstructured":"Yerke JR, Sacha GL, Scheraga RG, et al. Vasopressin plasma concentrations are not associated with hemodynamic response to exogenous vasopressin for septic shock. Pharmacotherapy. 2020;40:33\u20139.","journal-title":"Pharmacotherapy"},{"key":"3911_CR45","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/cc8224","volume":"15","author":"JA Russell","year":"2011","unstructured":"Russell JA. Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care. 2011;15:226.","journal-title":"Crit Care"},{"key":"3911_CR46","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/CCM.0000000000003544","volume":"47","author":"PJ Gleeson","year":"2019","unstructured":"Gleeson PJ, Crippa IA, Mongkolpun W, et al. Renin as a marker of tissue-perfusion and prognosis in critically ill patients. Crit Care Med. 2019;47:152\u20138.","journal-title":"Crit Care Med"},{"key":"3911_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","volume":"24","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Wunderink RG, Szerlip H, et al. Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock. Crit Care. 2020;24:43.","journal-title":"Crit Care"},{"key":"3911_CR48","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/CCM.0000000000003582","volume":"47","author":"AK Khanna","year":"2019","unstructured":"Khanna AK. Tissue perfusion and prognosis in the critically ill-Is renin the new lactate? Crit Care Med. 2019;47:288\u201390.","journal-title":"Crit Care Med"},{"key":"3911_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/CCM.0000000000005157","volume":"50","author":"AK Khanna","year":"2022","unstructured":"Khanna AK. Renin kinetics and mortality-same, same but different? Crit Care Med. 2022;50:153\u20137.","journal-title":"Crit Care Med"},{"key":"3911_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13613-019-0536-5","volume":"9","author":"KR Ham","year":"2019","unstructured":"Ham KR, Boldt DW, McCurdy MT, et al. Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial. Ann Intensive Care. 2019;9:63.","journal-title":"Ann Intensive Care"},{"key":"3911_CR51","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s00134-019-05770-3","volume":"45","author":"B Venkatesh","year":"2019","unstructured":"Venkatesh B, Khanna AK, Cohen J. Less is more: catecholamine-sparing strategies in septic shock. Intensive Care Med. 2019;45:1810\u20132.","journal-title":"Intensive Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-03911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-03911-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-03911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T16:17:53Z","timestamp":1650298673000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-03911-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3911"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-03911-7","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"22 March 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PMW has previously received consulting fees from La Jolla Pharmaceutical Company. AKK received consulting fees and grant funding from La Jolla Pharmaceutical Company. AKK consults for Edwards Lifesciences, Medtronic, Potrero Medical, GE Healthcare, Philips North America, Caretaker Medical and Retia Medical. He is funded by an NIH\/NCATS KL2 award for assessment of blood pressure and oxygenation in postoperative patients and a Wake Forest Hypertension and Vascular Research award for studying the relationship between serum renin and outcomes in patients with septic shock.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"76"}}